|
Orthologous residues
|
|
HS1 (human): Y397‑p, HS1 (mouse): Y405‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mass spectrometry, mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
Jurkat (T lymphocyte), T lymphocyte-blood
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human, mouse
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
vanadate
|
|
|
|
increase
|
|
|
anti-CD3
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cytoskeletal reorganization, transcription, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
VAV1 (human)
|
|
Induces
|
|
cytoskeletal reorganization
|
co-immunoprecipitation
|
|